Connect Biopharma Holdings Limited Purchase Of Availableforsale Financial Assets
Connect Biopharma Holdings Limited (CNTB) reported Purchase Of Availableforsale Financial Assets of $1.57 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-16.
Discontinued › Notes
ifrs-full:PurchaseOfAvailableforsaleFinancialAssets · last filed 2024-04-16
CNY
| Period end | Purchase Of Availableforsale Financial Assets 6 month | Purchase Of Availableforsale Financial Assets 12 month |
|---|---|---|
| 2022-12-31 | 41.00M CNY 20-F · filed 2023-04-11 | |
| 2022-06-30 | 41.00M CNY 6-K · filed 2023-09-12 | |
| 2021-12-31 | 114.50M CNY 20-F · filed 2023-04-11 | |
| 2021-06-30 | 42.50M CNY 6-K · filed 2022-09-13 | |
| 2020-12-31 | 106.60M CNY 20-F · filed 2023-04-11 | |
| 2019-12-31 | 163.00M CNY 20-F · filed 2022-03-31 |
USD
| Period end | Purchase Of Availableforsale Financial Assets 6 month | Purchase Of Availableforsale Financial Assets 12 month | Purchase Of Availableforsale Financial Assets 12 month as first filed |
|---|---|---|---|
| 2023-12-31 | $1.57M 20-F · filed 2024-04-16 | ||
| 2022-12-31 | $6.46M 20-F · filed 2024-04-16 | $5.89M 20-F · filed 2023-04-11 | |
| 2022-06-30 | $6.11M 6-K · filed 2022-09-13 | ||
| 2021-12-31 | $17.96M 20-F · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |